Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 51–100 of 155 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06081920	A Study of IBI363 in Subjects With Advanced Melanoma	recruiting	Phase 2	180	Innovent Biologics (Suzhou) Co. Ltd.INDUSTRY	1	Jul 29, 2026	clinicaltrials
NCT07686835	Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.(FIGURE-IM)	recruiting	Phase 2	70	Radboud University Medical CenterOTHER	1	Jul 27, 2026	clinicaltrials